查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403472

2030 年合成基因組學市場預測：按產品、應用、最終用戶和地區進行的全球分析

Synthetic Genomics Market Forecasts to 2030 - Global Analysis By Product (Adapters, DNA Template, Klenow Fragment, Modifying Enzymes, Primers and Other Products), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球合成基因組市場規模將達到 303 億美元，預計到 2030 年將達到 787 億美元，預測期內複合年成長率為 14.6%。

合成生物學是一個快速發展的領域，涉及遺傳物質的生產和操作，包含在合成基因組學市場中。這個領域涉及創建、建構和改進用於多種用途的合成 DNA 序列，包括創建基因改造生物、人造細胞和客製化遺傳電路。合成基因組學對於醫學領域的藥物開發、基因治療和個體化醫療至關重要。在農業領域，它有助於創造具有更好特性的基因改造作物。

根據世界經濟論壇 2021 年 9 月發布的資料，由於針對病毒的 mRNA 疫苗的開發，合成生物學的進步在控制流行病方面具有巨大潛力。

加大研發投入

隨著合成基因組學的快速發展，需要額外的研發資金來促進創新和新技術。這些投資用於資助 DNA 合成、基因編輯和其他遺傳物質操作的尖端方法的探索。此外，公共和私營部門都認知到合成基因組在醫療保健、農業和工業應用中的巨大潛力，因此增加了對研究計畫的財政支持。

研發成本高

由於基因工程複雜且需要尖端技術，中小型企業和研究機構被認為很難進入市場。創建先進的基因編輯工具、DNA合成技術和其他重要技術需要大量資金，這阻礙了許多人從事這一領域的工作。然而，公司在合成基因組學領域探索和創新的能力可能會受到大量初始投資和持續研發成本的限制。

合成生物學解決方案的需求不斷成長

合成基因組學是合成生物學的一個方面，它正在促進各個領域對創新和適應性生物解決方案不斷成長的需求。隨著公司和教育機構意識到合成基因組學在創造和修改遺傳物質方面具有巨大潛力，對客製化生物系統的需求正在增加。這種需求的應用範圍很廣，包括工業生物技術、醫療保健、農業等。此外，利用合成基因組學，可以對生物體進行工程改造以執行特定任務，例如為工業過程創造生物基材料、具有改進特性的基因工程作物以及藥物治療。

安全和生物安全問題

由於操縱遺傳物質和產生合成生物體的可能性，引起了人們對將合成基因組學用於邪惡目的的擔憂。為了減輕這些擔憂，政府和監管機構必須制定嚴格的法律，禁止非法取得基因技術。可能會製造出具有惡意目的的基因改造生物，例如生物武器，因此需要採取有效的安全預防措施。然而，由於這些擔憂，合成基因組市場的公司難以管理合規性要求，減緩了監管核准流程並加強了審查。

新冠肺炎 (COVID-19) 影響：

全球健康危機已經證明了尖端基因技術在疫苗開發、診斷和替代療法方面的重要性。合成基因組學使 mRNA 疫苗的快速發展成為可能，並證明該技術可以快速適應新出現的感染疾病。疫情推遲了研究舉措、扭轉了供應鏈並將資源用於緊急醫療保健需求，間接影響了市場成長軌跡。資金籌措限制和經濟不確定性影響了該行業規模較小的參與者。

DNA模板片段預計在預測期內是最大的

由於 DNA 模板對於準確有效地合成遺傳物質至關重要，因此它在合成基因組學市場中佔據最大佔有率。 DNA 合成技術的進步，包括自動化 DNA 合成平台和創新方法，現在使研究和生物技術研究人員能夠以前所未有的速度和精度設計和製造客製化的 DNA 序列。此外，各種應用（包括基因治療、藥物藥物研發和基因改造牲畜的培育）對合成生物解決方案的需求不斷成長，也是推動 DNA 模板領域興起的因素。

預計器官移植產業在預測期內複合年成長率最高。

由於器官移植在解決器官短缺相關挑戰方面具有變革性作用，預計該產業在預測期內將出現盈利成長。為了解決與器官排斥和器官稀缺相關的問題，合成基因體學已成為生產具有更高相容性的器官和組織的有效方法。此外，精確基因工程器官的能力提供了為特定患者量身定做移植物、抑制免疫反應並提高移植成功率的潛力。

佔比最大的地區：

在預測期內，亞太地區佔據了最大的市場佔有率。這是由於該地區經濟的快速工業化和技術進步，以及人們日益認知到合成基因組學在許多領域的革命性潛力。中國、日本、印度等國家正在進行大規模的研發投入，為合成基因體學的發展創造了完美的環境。學術機構、研究機構和生物技術公司積極推動前沿舉措，以促進創新和新應用的創造。

複合年成長率最高的地區：

隨著對精準醫療和個人化醫療保健的日益關注，由於醫療保健相關計劃的增加，亞太地區正在經歷盈利成長。合成基因組學對於這些努力至關重要，因為它能夠客製化遺傳干預、基因療法和診斷工具。合成基因組學技術的使用因其解決當地健康問題和提供定製藥物療法的潛力而受到推動。此外，新加坡和中國等國家的政府正在積極支持合成生物學和生物技術領域的努力，投入資源和基礎設施來支持這些領域的研究和開發的進步。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球合成基因體學市場：依產品

  • 適配器
  • 脫氧核糖核酸模板
  • 克列諾的碎片
  • 酵素修飾
  • 底漆
  • 其他產品

第6章全球合成基因體學市場：依應用分類

  • 細菌抗藥性
  • DNA列印
  • 創新疫苗和治療方法
  • 營養蛋白質和油
  • 器官移植
  • 其他用途

第7章全球合成基因組學市場：依最終用戶分類

  • 學術機構
  • 生技公司
  • 受託研究機構
  • 政府研究所
  • 製藥公司
  • 其他最終用戶

第8章全球合成基因體學市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Biocompare Inc
  • Boster Biological Technology
  • Eurofins Genomics
  • Genewiz
  • GenScript
  • Integrated DNA Technologies Inc
  • Synthetic Genomics Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience
Product Code: SMRC24697

According to Stratistics MRC, the Global Synthetic Genomics Market is accounted for $30.3 billion in 2023 and is expected to reach $78.7 billion by 2030 growing at a CAGR of 14.6% during the forecast period. The rapidly growing field of synthetic biology, which involves the production and manipulation of genetic material, is included in the Synthetic Genomics Market. It involves the creation, building, and refinement of synthetic DNA sequences for a variety of applications, including the creation of genetically modified creatures, artificial cells, and tailored genetic circuits. Synthetic genomics is essential to drug development, gene therapy, and customized medicine in the field of medicine. It aids in the creation of genetically engineered crops with enhanced attributes in agriculture.

According to a data published by the World Economic Forum in September 2021, the advancements in the synthetic biology have a vast potential to manage the pandemic for the development of mRNA vaccine against virus.

Market Dynamics:

Driver:

Growing investments in research and development activities

As synthetic genomics develops rapidly, additional funding for research and development is needed to promote innovation and new technologies. These investments fund the examination of cutting-edge methods for DNA synthesis, gene editing, and other genetic material manipulation. Additionally, growing financial support for research initiatives is a result of both the public and private sectors recognizing the enormous potential of synthetic genomes in healthcare, agriculture, and industrial applications.

Restraint:

High costs of research and development

Due to the complexity of genetic engineering and the requirement for cutting-edge technologies, smaller businesses and research institutions consider it difficult to enter the market. Significant money is needed to create advanced gene editing tools, DNA synthesis techniques, and other critical technologies, which prevents numerous individuals from working in this field. However, companies' capacity to explore and innovate in synthetic genomics may be constrained by the significant initial investment and ongoing research and development costs.

Opportunity:

Rising demand for synthetic biology solutions

Synthetic genomics, a fundamental aspect of synthetic biology, contributes to the growing demand for innovative and adaptable biological solutions in a range of sectors. Customized biological systems are becoming more and more in demand as companies and educational institutions realize the enormous promise synthetic genomics has for creating and modifying genetic material. Applications for this demand are wide-ranging and include industrial biotechnology, healthcare, and agriculture. Moreover, with the use of synthetic genomics, biological organisms can be designed to do specific duties, such as creating bio-based materials for industrial processes, genetically modified crops with improved features, and medicinal treatments.

Threat:

Security and biosecurity concerns

Fears regarding the exploitation of synthetic genomics for malevolent terminates are triggered by the manipulation of genetic material and the potential production of synthetic creatures. To mitigate these worries, governments and regulatory agencies must impose stringent laws that prohibit illegal access to genetic technologies. Effective safety precautions are necessary due to the possibility of creating genetically modified organisms with malicious intent, such as bioweapons. However, companies in the synthetic genome market find it difficult to manage compliance requirements as a result of these worries, which also slow down the regulatory approval process and raise scrutiny.

COVID-19 Impact:

The relevance of cutting-edge genetic technologies for vaccine development, diagnostics, and treatment alternatives has been demonstrated by the global health crisis. The rapid development of mRNA vaccinations was made possible by synthetic genomics, demonstrating the technology's capacity to adapt rapidly to new infections. The pandemic managed to indirectly affect the market's growth trajectory by delaying research initiatives, reversing supply chains, and directing resources to urgent healthcare requirements. Funding limitations and economic uncertainty had an impact on the industry's smaller participants.

The DNA template segment is expected to be the largest during the forecast period

Due to its crucial significance in the accurate and effective synthesis of genetic material, the DNA template segment held the largest share in the synthetic genomics market. Researchers and biotechnologists can design and manufacture customized DNA sequences with previously unattainable speed and accuracy because of advancements in DNA synthesis technology, including automated DNA synthesis platforms and innovative approaches. Furthermore, the growing need for synthetic biology solutions for a variety of applications, such as gene therapy, drug discovery, and the generation of genetically modified livestock, is the factor that is causing this rise in the DNA template sector.

The organ transplantation segment is expected to have the highest CAGR during the forecast period

Because organ transplantation has a transformative effect on addressing the challenges associated with organ shortages, the segment is expected to grow profitably during the projected period. To address the issues associated with organ rejection and scarcity, synthetic genomics has emerged as a potentially efficient way of producing organs and tissues with improved compatibility. Additionally, the capacity to precisely modify organs genetically offers the possibility of customizing grafts for particular patients, reducing immunological reactions, and raising transplant success rates.

Region with largest share:

Over the course of the projected period, the Asia Pacific region had the largest share of the market due to the region's economies experiencing rapid industrialization and technological improvement, as well as the increasing awareness of the revolutionary potential of synthetic genomics across numerous sectors. Significant R&D investments have been made by nations like China, Japan, and India, creating an optimal environment for the development of synthetic genomics. Cutting-edge initiatives are being actively promoted by academic institutions, research organizations, and biotech corporations, which promote innovation and the creation of new applications.

Region with highest CAGR:

With an increasing focus on precision medicine and tailored healthcare, the Asia-Pacific area is experiencing profitable growth as a result of an increase in healthcare-related projects. Because it renders it feasible to customize genetic interventions, gene therapies, and diagnostic tools, synthetic genomics is essential to these initiatives. The use of synthetic genomics technology is being propelled by its potential to address regional health concerns and offer customized medicinal therapies. Moreover, governments in nations like Singapore and China are actively supporting efforts in the domains of synthetic biology and biotechnology, offering resources and infrastructure to support the advancement of these fields' research and development.

Key players in the market:

Some of the key players in Synthetic Genomics market include Biocompare Inc , Boster Biological Technology, Eurofins Genomics, Genewiz, GenScript, Integrated DNA Technologies Inc, Synthetic Genomics Inc, Thermo Fisher Scientific Inc and Twist Bioscience .

Key Developments:

In October 2023, Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the company's 35-year-history-its entrance into the therapeutics space-and enables IDT to manufacture products for research use through to current good manufacturing practice (cGMP) grade cell and gene therapy reagents to provide researchers with a single partner that can help them rapidly transition from the lab to therapeutic development.

In February 2023, Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, announced a strategic collaboration with global genomics solutions provider Integrated DNA Technologies (IDT) to enable key next generation sequencing (NGS) applications on Ultima platforms.

In February 2023, Twist Bioscience announces technology early access of enhanced whole genome sequencing solution at AGBT. eWGS is a novel solution that enables researchers to obtain simultaneous low-pass whole genome data together with deep coverage of selected regions, in a high-throughput and cost-effective workflow.

Products Covered:

  • Adapters
  • DNA Template
  • Klenow Fragment
  • Modifying Enzymes
  • Primers
  • Other Products

Applications Covered:

  • Bacterial Resistance
  • DNA Printing
  • Innovative Vaccines & Therapeutics
  • Nutritional Proteins & Oils
  • Organ Transplantation
  • Other Applications

End Users Covered:

  • Academic Institutions
  • Biotechnology Companies
  • Contract Research Organizations
  • Government Laboratories
  • Pharmaceutical companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Synthetic Genomics Market, By Product

  • 5.1 Introduction
  • 5.2 Adapters
  • 5.3 DNA Template
  • 5.4 Klenow Fragment
  • 5.5 Modifying Enzymes
  • 5.6 Primers
  • 5.7 Other Products

6 Global Synthetic Genomics Market, By Application

  • 6.1 Introduction
  • 6.2 Bacterial Resistance
  • 6.3 DNA Printing
  • 6.4 Innovative Vaccines & Therapeutics
  • 6.5 Nutritional Proteins & Oils
  • 6.6 Organ Transplantation
  • 6.7 Other Applications

7 Global Synthetic Genomics Market, By End User

  • 7.1 Introduction
  • 7.2 Academic Institutions
  • 7.3 Biotechnology Companies
  • 7.4 Contract Research Organizations
  • 7.5 Government Laboratories
  • 7.6 Pharmaceutical companies
  • 7.7 Other End Users

8 Global Synthetic Genomics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Biocompare Inc
  • 10.2 Boster Biological Technology
  • 10.3 Eurofins Genomics
  • 10.4 Genewiz
  • 10.5 GenScript
  • 10.6 Integrated DNA Technologies Inc
  • 10.7 Synthetic Genomics Inc
  • 10.8 Thermo Fisher Scientific Inc
  • 10.9 Twist Bioscience

List of Tables

  • Table 1 Global Synthetic Genomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 4 Global Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 5 Global Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 6 Global Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 7 Global Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 8 Global Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 10 Global Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 11 Global Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 12 Global Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 13 Global Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 14 Global Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 15 Global Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 18 Global Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 19 Global Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 20 Global Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 21 Global Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 22 Global Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 25 North America Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 26 North America Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 27 North America Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 28 North America Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 29 North America Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 30 North America Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 31 North America Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 North America Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 33 North America Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 34 North America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 35 North America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 36 North America Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 37 North America Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 38 North America Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 North America Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 40 North America Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 41 North America Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 42 North America Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 43 North America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 44 North America Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 47 Europe Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 48 Europe Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 49 Europe Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 50 Europe Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 51 Europe Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 52 Europe Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 53 Europe Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 54 Europe Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 55 Europe Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 56 Europe Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 57 Europe Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 58 Europe Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 59 Europe Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 60 Europe Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 61 Europe Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 62 Europe Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 63 Europe Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 64 Europe Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 65 Europe Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 66 Europe Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 69 Asia Pacific Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 70 Asia Pacific Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 71 Asia Pacific Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 72 Asia Pacific Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 73 Asia Pacific Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 74 Asia Pacific Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 75 Asia Pacific Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 Asia Pacific Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 77 Asia Pacific Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 78 Asia Pacific Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 79 Asia Pacific Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 80 Asia Pacific Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 81 Asia Pacific Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 82 Asia Pacific Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 83 Asia Pacific Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 84 Asia Pacific Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 85 Asia Pacific Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 86 Asia Pacific Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 87 Asia Pacific Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 88 Asia Pacific Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 91 South America Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 92 South America Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 93 South America Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 94 South America Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 95 South America Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 96 South America Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 97 South America Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 98 South America Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 99 South America Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 100 South America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 101 South America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 102 South America Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 103 South America Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 104 South America Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 South America Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 106 South America Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 107 South America Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 108 South America Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 109 South America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 110 South America Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Synthetic Genomics Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Synthetic Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 113 Middle East & Africa Synthetic Genomics Market Outlook, By Adapters (2021-2030) ($MN)
  • Table 114 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Template (2021-2030) ($MN)
  • Table 115 Middle East & Africa Synthetic Genomics Market Outlook, By Klenow Fragment (2021-2030) ($MN)
  • Table 116 Middle East & Africa Synthetic Genomics Market Outlook, By Modifying Enzymes (2021-2030) ($MN)
  • Table 117 Middle East & Africa Synthetic Genomics Market Outlook, By Primers (2021-2030) ($MN)
  • Table 118 Middle East & Africa Synthetic Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 119 Middle East & Africa Synthetic Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 120 Middle East & Africa Synthetic Genomics Market Outlook, By Bacterial Resistance (2021-2030) ($MN)
  • Table 121 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Printing (2021-2030) ($MN)
  • Table 122 Middle East & Africa Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2021-2030) ($MN)
  • Table 123 Middle East & Africa Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2021-2030) ($MN)
  • Table 124 Middle East & Africa Synthetic Genomics Market Outlook, By Organ Transplantation (2021-2030) ($MN)
  • Table 125 Middle East & Africa Synthetic Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 126 Middle East & Africa Synthetic Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 127 Middle East & Africa Synthetic Genomics Market Outlook, By Academic Institutions (2021-2030) ($MN)
  • Table 128 Middle East & Africa Synthetic Genomics Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Synthetic Genomics Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 130 Middle East & Africa Synthetic Genomics Market Outlook, By Government Laboratories (2021-2030) ($MN)
  • Table 131 Middle East & Africa Synthetic Genomics Market Outlook, By Pharmaceutical companies (2021-2030) ($MN)
  • Table 132 Middle East & Africa Synthetic Genomics Market Outlook, By Other End Users (2021-2030) ($MN)